Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-23 Purchase | 2022-05-24 4:47 pm | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 20,000 | $0.84 | $16,800 | 20,600 (Direct) | View |
| 2022-05-17 Purchase | 2022-05-19 7:43 pm | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 10,000 | $0.8228 | $8,228 | 10,000 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-18 4:43 pm | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 30,000 | $0.8526 | $25,578 | 50,000 (Direct) | View |
| 2022-05-13 Purchase | 2022-05-17 6:28 pm | Adverum Biotechnologies Inc. | ADVM | D'Souza Rupert CFO | 20,000 | $0.84285 | $16,857 | 20,850 (Direct) | View |
| 2022-04-20 Purchase | 2022-04-22 5:00 pm | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO | 25,000 | $1.112 | $27,800 | 762,462 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-20 4:35 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 21,925 | $1.14 | $24,994 | 280,556 (Direct) | View |
| 2021-12-08 Purchase | 2021-12-10 5:26 pm | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO | 25,000 | $1.8244 | $45,609 | 737,462 (Direct) | View |
| 2021-12-08 Purchase | 2021-12-10 5:26 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 25,000 | $1.91 | $47,750 | 258,631 (Direct) | View |
| 2021-11-15 Sale | 2021-11-17 4:38 pm | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 50,000 | $2.18 | $109,000 | 3,334 (Indirect) | View |
| 2021-09-30 Sale | 2021-10-04 5:36 pm | Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer | 4,766 | $2.17 | $10,342 | 164,723 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-10 Option Award | 2022-06-14 4:23 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:22 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:22 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:21 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:20 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:19 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 52,500 | $0 | 52,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:39 pm | N/A 2032-06-07 | Adverum Biotechnologies Inc. | ADVM | Rakow John CFO | 250,000 | $0 | 250,000 (Direct) | View |
| 2022-06-03 Ownership | 2022-06-10 4:37 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rakow John CFO | 0 | $0 | 423,771 (Direct) | View |
| 2022-06-06 Ownership | 2022-06-07 7:11 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | PECOTA NANCY E Principal Accounting Officer | 0 | $0 | 0 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:15 pm | N/A 2032-03-16 | Adverum Biotechnologies Inc. | ADVM | Hong Soo Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-17 Ownership | 2022-03-18 5:14 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Hong Soo Director | 0 | $0 | 0 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-18 5:12 pm | N/A 2032-03-16 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-17 Ownership | 2022-03-18 5:11 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director | 0 | $0 | 0 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-17 4:53 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer | 195,000 | $0 | 195,000 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-17 4:51 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 255,000 | $0 | 255,000 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-17 4:50 pm | N/A 2032-03-07 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO | 630,000 | $0 | 630,000 (Direct) | View |
| 2022-02-07 Option Award | 2022-02-09 5:10 pm | N/A 2032-02-06 | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 485,000 | $0 | 485,000 (Direct) | View |
| 2022-02-07 Ownership | 2022-02-09 5:08 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 5:04 pm | N/A 2032-01-05 | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2022-01-06 Ownership | 2022-01-10 5:02 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer | 0 | $0 | 600 (Direct) | View |
| 2021-12-06 Option Award | 2021-12-08 5:26 pm | N/A 2031-12-05 | Adverum Biotechnologies Inc. | ADVM | D'Souza Rupert CFO | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-12-06 Ownership | 2021-12-08 5:24 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | D'Souza Rupert CFO | 0 | $0 | 850 (Direct) | View |
| 2021-09-02 Ownership | 2021-09-14 4:50 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer | 0 | $0 | 610,000 (Direct) | View |
| 2021-09-02 Ownership | 2021-09-13 5:49 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | THRIFT JACK ANTHONY CFO | 0 | $0 | 0 (Direct) | View |
| 2021-08-06 Option Award | 2021-08-10 9:26 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer | 120,000 | $0 | 169,489 (Direct) | View |
| 2021-08-06 Option Award | 2021-08-10 9:25 pm | N/A 2031-08-05 | Adverum Biotechnologies Inc. | ADVM | Thedinga Angela CTO | 270,000 | $0 | 270,000 (Direct) | View |
| 2021-08-06 Option Award | 2021-08-10 9:24 pm | N/A 2031-08-05 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter See Remarks section | 380,000 | $0 | 390,692 (Direct) | View |
| 2021-08-06 Option Award | 2021-08-10 9:23 pm | N/A 2031-08-05 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO | 1,135,000 | $0 | 1,161,292 (Direct) | View |
| 2021-06-24 Ownership | 2021-06-29 6:53 pm | N/A 2031-02-17 | Adverum Biotechnologies Inc. | ADVM | DeRespino Christopher See Remarks | 0 | $0 | 425,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 6:57 pm | N/A 2031-05-31 | Adverum Biotechnologies Inc. | ADVM | Clark Julie Chief Medical Officer | 400,000 | $0 | 400,000 (Direct) | View |